These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19934385)

  • 41. Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients.
    Crommentuyn KM; Kappelhoff BS; Mulder JW; Mairuhu AT; van Gorp EC; Meenhorst PL; Huitema AD; Beijnen JH
    Br J Clin Pharmacol; 2005 Oct; 60(4):378-89. PubMed ID: 16187970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modifications.
    la Porte CJ; Schippers EF; van der Ende ME; Koopmans PP; Blok WL; Kauffmann RH; Kroon FP; Burger DM
    AIDS; 2005 Jul; 19(10):1105-7. PubMed ID: 15958844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of lopinavir/ritonavir and darunavir/ritonavir on the HIV integrase inhibitor S/GSK1349572 in healthy participants.
    Song I; Min SS; Borland J; Lou Y; Chen S; Patel P; Ishibashi T; Piscitelli SC
    J Clin Pharmacol; 2011 Feb; 51(2):237-42. PubMed ID: 20489027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tacrolimus and lopinavir/ritonavir interaction in liver transplantation.
    Schonder KS; Shullo MA; Okusanya O
    Ann Pharmacother; 2003 Dec; 37(12):1793-6. PubMed ID: 14632538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased dose of lopinavir/ritonavir compensates for efavirenz-induced drug-drug interaction in HIV-1-infected children.
    Bergshoeff AS; Fraaij PL; Ndagijimana J; Verweel G; Hartwig NG; Niehues T; De Groot R; Burger DM
    J Acquir Immune Defic Syndr; 2005 May; 39(1):63-8. PubMed ID: 15851915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lopinavir/ritonavir: appraisal of its use in HIV therapy.
    von Hentig N
    Drugs Today (Barc); 2007 Apr; 43(4):221-47. PubMed ID: 17460785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ABT-378: a second generation protease inhibitor.
    Highleyman L
    BETA; 1998 Oct; ():8, 55. PubMed ID: 11365998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monoboosted lopinavir/ritonavir as simplified second-line maintenance therapy in virologically suppressed children.
    Bunupuradah T; Kosalaraksa P; Puthanakit T; Mengthaisong T; Wongsabut J; Lumbiganon P; Phanuphak P; Burger D; Pancharoen C; Ananworanich J;
    AIDS; 2011 Jan; 25(3):315-23. PubMed ID: 21157298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection.
    Kaplan SS; Hicks CB
    Expert Opin Pharmacother; 2005 Aug; 6(9):1573-85. PubMed ID: 16086645
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lopinavir/ritonavir dosage form affects quality of life during monotherapy in HIV-positive adults.
    Yeh RF; Lipman BA; Mayberry C; Miguel B; Nemecek JJ; Gathe JC
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(5):273-7. PubMed ID: 20841439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simplification of therapeutic drug monitoring for twice-daily regimens of lopinavir/ritonavir for HIV infection.
    Alexander CS; Montaner JS; Asselin JJ; Ting L; McNabb K; Harris M; Guillemi S; Harrigan PR
    Ther Drug Monit; 2004 Oct; 26(5):516-23. PubMed ID: 15385834
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulation.
    Hull MW; Harris M; Lima V; Guillemi S; Harrigan PR; Montaner JS
    J Clin Pharmacol; 2009 Feb; 49(2):155-61. PubMed ID: 19179294
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lopinavir.
    Hurst M; Faulds D
    Drugs; 2000 Dec; 60(6):1371-9; discussion 1380-1. PubMed ID: 11152017
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of acid reduction with a proton pump inhibitor on the pharmacokinetics of lopinavir or ritonavir in HIV-infected patients on lopinavir/ritonavir-based therapy.
    Overton ET; Tschampa JM; Klebert M; Royal M; Rodriguez M; Spitz T; Kim G; Mondy KE; Acosta EP
    J Clin Pharmacol; 2010 Sep; 50(9):1050-5. PubMed ID: 20147613
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacokinetic evidence for the induction of lopinavir metabolism by efavirenz.
    Dailly E; Allavena C; Raffi F; Jolliet P
    Br J Clin Pharmacol; 2005 Jul; 60(1):32-4. PubMed ID: 15963091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Disseminated histoplasmosis in AIDS].
    Albrecht H; Stellbrink HJ; Petersen J; Patzak A; Jäger H; Greten H
    Dtsch Med Wochenschr; 1994 May; 119(18):657-62. PubMed ID: 8187612
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Re: Acknowledgement of human bioequivalency of matrix's lopinavir-ritonavir formulation to Kaletra, comment to article on Bioavailability of generic ritonavir and lopinavir/ritonavir tablet products in a dog model, by Garren et al.
    Rackley RJ
    J Pharm Sci; 2010 Feb; 99(2):568-71; author reply 574. PubMed ID: 19746411
    [No Abstract]   [Full Text] [Related]  

  • 58. Response to the comparison of generic ritonavir (Ritomune, Cipla) and lopinavir/ritonavir tablets (Lopimune, Cipla) and the Abbott brand (Norvir soft-gel capsules and Kaletra tablets).
    Chachad S; Gogtay J; Malhotra G; Purandare S
    J Pharm Sci; 2010 Feb; 99(2):572-3; author reply 574. PubMed ID: 19718766
    [No Abstract]   [Full Text] [Related]  

  • 59. Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children.
    Elsherbiny D; Ren Y; McIlleron H; Maartens G; Simonsson US
    Eur J Clin Pharmacol; 2010 Oct; 66(10):1017-23. PubMed ID: 20552180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lack of effect of gastric acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir in HIV-infected patients.
    Chiu YL; Klein CE; Woodward WC; King KR; Naylor C; Awni W; Brun S
    AIDS Patient Care STDS; 2007 Apr; 21(4):247-51. PubMed ID: 17461719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.